Search Results - "Perrotti, A."

Infectious complications in patients receiving ticagrelor or clopidogrel before coronary artery bypass grafting by Dalén, M., Biancari, F., Perrotti, A., Mariscalco, G., Onorati, F., Faggian, G., Franzese, I., Salsano, A., Santini, F., Ruggieri, V.G., Maselli, D., Nardella, S., Santarpino, G., Fischlein, T., Saccocci, M., Zanobini, M., Musumeci, F., Gherli, R., Rubino, A.S., De Feo, M., Bancone, C., Nicolini, F., Kinnunen, E.-M., Tauriainen, T., Reichart, D., Demal, T., Gatti, G., Khodabandeh, S., Holm, M.

“…The antiplatelet agent ticagrelor has recently been found to have bactericidal activity, demonstrated in vitro and in an in vivo mouse model, which warrants…”
Get full text

Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies by Niscola, P, Romani, C, Scaramucci, L, Dentamaro, T, Cupelli, L, Tendas, A, Piccioni, D, Giovannini, M, Tolu, B, Cartoni, C, Arcuri, E, Perrotti, A, Palumbo, R, de Fabritiis, P

“…Severe pain syndromes may be recorded during all phases of haematopoietic stem cell transplantation (HSCT) for haematological malignancies: from stem cell…”
Get full text

RF67 REDO MITRAL SURGERY AND HOSPITAL OUTCOME: A MULTICENTRE EXPERIENCE REGARDING SURGICAL FACTORS AND COMPLICATIONS by Franzese, I, Biagio, L San, Perrotti, A, Mariscalco, G, Francica, A, Lucarelli, C, De Feo, M, Santarpino, G, Salsano, A, Rubino, A, Gatti, G, Beghi, C, Mignosa, C, Pappalardo, A, Onorati, F, Santini, F, Faggian, G

“…BACKGROUND AND AIM:Redo mitral surgery is an high risk procedure. Several preoperative conditions identify patients at unusual surgical risk. Few studies…”
Get full text

OC62 REDO MITRAL SURGERY AND HOSPITAL OUTCOME: IMPACT OF FAILED MITRAL VALVE REPAIR by Franzese, I, Biagio, L San, Gatti, G, Perrotti, A, Mariscalco, G, Milano, A.D, De Feo, M, Rubino, A, Santarpino, G, Salsano, A, Lucarelli, C, Francica, A, Beghi, C, Mignosa, C, Pappalardo, A, D’Errigo, P, Santini, F, Onorati, F, Faggian, G

“…BACKGROUND AND AIM:Mitral valve repair is the gold standard for mitral valve regurgitation, even if failed mitral repairs (FMR) have been reported. The aim of…”
Get full text

Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network by Tendas, A, Cupelli, L, Mauroni, M R, Sollazzo, F, Di Piazza, F, Saltarelli, D, Carli, I, Chierichini, A, Melfa, C, Surano, M, Annibali, O, Piedimonte, M, Conte, E, Marchesi, F, Viggiani, C, Pignatelli, A C, Dentamaro, T, Niscola, P, de Fabritiis, P, Perrotti, A P, Arcese, W

Get full text

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer: comment by Tendas, A., Scaramucci, L., Cupelli, L., Lentini, R., Trawinska, M. M., Giovannini, M., Perrotti, A., Fabritiis, P., Niscola, P.

Get full text

OC88 COMPARATIVE ANALYSIS OF PROTHROMBIN COMPLEX CONCENTRATE AND FRESH FROZEN PLASMA IN THE MANAGEMENT OF PERIOPERATIVE BLEEDING AFTER CORONARY ARTERY BYPASS GRAFTING by Salsano, A, Mariscalco, G, Santini, F, Ruggieri, V.G, Perrotti, A, Chocron, S, Gherli, R, Reichart, D, Demal, T, Faggian, G, Franzese, I, Dalén, M, Santarpino, G, Fischlein, T, Rubino, A.S, Maselli, D, Nardella, S, Nicolini, F, Saccocci, M, Gatti, G, Bounader, K, Rosato, S, Kinnunen, E, De Feo, M, Tauriainen, T, Onorati, F, Biancari, F

“…BACKGROUND AND AIM:Recent studies suggested that prothrombin complex concentrate (PCC) might be more effective than fresh frozen plasma (FFP) to reduce red…”
Get full text

OC11 CLINICAL FRAILTY SCALE AND OUTCOME AFTER CORONARY ARTERY BYPASS GRAFTING: AN ANALYSIS OF THE E-CABG REGISTRY by Saccocci, M, Reichart, D, Rosato, S, Nammas, W, Onorati, F, Dalen, M, Castro, L, Gherli, R, Gatti, G, Franzese, I, Faggian, G, De Feo, M, Khodabandeh, S, Santarpino, G, Rubino, A.S, Maselli, D, Nardella, S, Salsano, A, Nicolini, F, Zanobini, M, Bounader, K, Kinnunen, E, Tauriainen, T, Airaksinen, J, Seccareccia, F, Mariscalco, G, Ruggieri, V.G, Perrotti, A, Biancari, F

“…OBJECTIVES:The aim of this study was to assess the impact of frailty on the outcome after coronary artery bypass grafting (CABG) and whether it mayimprove the…”
Get full text

OC87 VALUE OF SCREENING ASYMPTOMATIC CAROTID ARTERY STENOSIS PRIOR TO CORONARY ARTERY BYPASS GRAFTING: ANALYSIS OF THE E-CABG REGISTRY by Salsano, A, Santarpino, G, Santini, F, Nicolini, F, De Feo, M, Dalén, M, Fischlein, T, Perrotti, A, Reichart, D, Gatti, G, Onorati, F, Franzese, I, Faggian, G, Bancone, C, Chocron, S, Khodabandeh, S, Rubino, A.S, Maselli, D, Nardella, S, Gherli, R, Zanobini, M, Saccocci, M, Bounader, K, Rosato, S, Tauriainen, T, Mariscalco, G, Airaksinen, J, Ruggieri, V.G, Biancari, F

“…BACKGROUND AND AIM:The aim of this study was to evaluate the prognostic impact of asymptomatic carotid artery stenosis(CAS) in patients undergoing isolated…”
Get full text

Lenalidomide cutaneous adverse event: a case of Stevens–Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone by Siniscalchi, A., Tendas, A., Morino, L., Dentamaro, T., De Bellis, A., Perrotti, A., de Fabritiis, P., Musto, P., Caravita, T.

“…Stevens-Johnson syndrome (SJS) is a potentially deadly skin disease that usually results from a drug reaction. Typically, it involves the skin and mucous…”
Get full text

P-170 Clinical complications in outpatient myelodysplastic syndromes by Tendas, A, Niscola, P, Cupelli, L, Scaramucci, L, Giovannini, M, Piccioni, D, Dentamaro, T, Perrotti, A, De fabritiis, P

Get full text

P-046 Atypical myelodysplastic/myeloproliferative neoplasm rapidly transformed to chronic myelomonocytic leukemia and acute myeloid leukemia in a laryngeal cancer patients by Niscola, P, Tendas, A, Catalano, G, Fratoni, S, Piccioni, D, Giovannini, M, Perrotti, A, De Fabritiis, P

Get full text

P-166 Disability and disease burden in outpatient myelodisplastic syndromes by Tendas, A, Cupelli, L, Giovannini, M, Catalano, G, Scaramucci, L, Perrotti, A, Niscola, P, De fabritiis, P

Get full text

P-177 Long-lasting erythroid response after discontinuation of human recombinant erythropoietin in MDS patients: Report of three cases by Niscola, P, Tendas, A, Giovannini, M, Scaramucci, L, Cupelli, L, Piccioni, D, Catalano, G, Perrotti, A, De Fabritiis, P

Get full text

P-044 Concomitant heterozygous β-thalassemia and myelodysplastic syndromes by Niscola, P, Tendas, A, Giovannini, M, Scaramucci, L, Fratoni, S, Perrotti, A, De Fabritiis, P

Get full text

P-269 Concomitant heterozygous β-thalassemia and myelodysplastic syndromes by Niscola, P, Tendas, A, Giovannini, M, Scaramucci, L, Fratoni, S, Perrotti, A, De Fabritiis, P

Get full text

P-271 Atypical myelodysplastic/myeloproliferative neoplasm rapidly transformed to chronic myelomonocytic leukemia and acute myeloid leukemia in a laryngeal cancer patients by Niscola, P, Tendas, A, Catalano, G, Fratoni, S, Piccioni, D, Giovannini, M, Perrotti, A, De Fabritiis, P

Get full text

Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura by Stasi, R, Stipa, E, Masi, M, Cecconi, M, Scimò, M T, Oliva, F, Sciarra, A, Perrotti, A P, Adomo, G, Amadori, S

“…To define response to therapy and ultimate outcome of adults with idiopathic thrombocytopenic purpura (ITP). We retrospectively analyzed patients with ITP…”
Get more information

P-176 Hypomethylating therapy in the management of an old older patient with myelodysplastic syndrome followed in a home care program by Niscola, P, Tendas, A, Palombi, M, Trawinska, M.M, Cupelli, L, Giovannini, M, Scaramucci, L, Catalano, G, Perrotti, A, De Fabritiis, P

Get full text

346 Home care management of transfusions in patients with myelodysplastic syndromes by Niscola, P, Trawinska, M.M, Tendas, A, Giovannini, M, Palombi, M, Cupelli, L, Perrotti, A, De Meis, I, de Fabritiis, P

Get full text